IndiaOne Finance - Company Dashboard

Governance Classic Home

Lyka Labs LtdPharmaceuticalsINE933A01014Consolidated₹83.40-0.68 (-0.81%)Jun-26

Valuation

Market Cap₹301.30 Cr

TTM PE-32.81x

Forward PE-39.07x

PEG2.93

Book Value₹25.56

P/B3.26x

TTM EPS₹-2.54

Fwd EPS₹-2.13

TTM Revenue₹137.73 Cr

TTM PAT₹-9.38 Cr

TTM EBITDA₹-2.79 Cr

TTM EBIT₹-11.15 Cr

Last Qtr PAT₹2.05 Cr

Last Qtr EBITDA₹4.55 Cr

Last Qtr EBIT₹2.54 Cr

Profitability

ROE-10.15%

ROCE-2.36%

TTM NPM-6.81%

TTM EBITDA %-2.03%

Curr OPM4.80%

Last OPM-28.18%

Curr NPM—

Last NPM—

Curr EPS₹0.57

Last EPS₹-2.13

Balance sheet

Equity₹35.69 Cr

Reserve₹56.70 Cr

Total Debt₹48.36 Cr

D/E0.52x

Interest %49.27%

Curr Interest₹1.01 Cr

Price / range

Close₹83.34

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.99%

1W+1.08%

1M+20.47%

3M+18.47%

6M+53.39%

1Y-16.66%

2Y-45.42%

3Y-25.59%

5Y-1.43%

Diwali+8.00%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	42.31+45.0%	28.03	30.73	32.97	29.18	120.91
Other Income	0.42	0.51	1.26	1.22	0.67	3.97
Total Income	42.73+43.2%	28.54	31.99	34.19	29.84	124.88
Interest	1.01	0.87	0.82	0.79	0.85	3.33
Expenditure	-40.73-42.1%	-35.43	-31.71	-38.98	-28.67	-135.10
PBDT	0	0	0	0	0	0
EBITDA	4.60+35.7%	-4.49	1.92	-3.15	3.39	-2.40
Depreciation	-2.01	-2.04	-2.08	-2.07	-2.03	-8.46
EBIT	2.59+90.4%	-6.53	-0.16	-5.22	1.36	-10.86
PBT	1.99+70.1%	-29.90	0.28	-4.80	1.17	-33.24
Tax	0.11	0.13	0	1.17	-0.36	0.95
Equity	36.15	35.69	0	0	35.69	35.69
OPM	4.66	-104.77	0.90	-14.55	3.92	-26.61
Net Profit	2.10+159.3%	-29.77	0.28	-3.63	0.81	-32.29
NPM	4.91	-104.31	0.91	-11.00	2.71	-25.86
EPS	0.58+163.6%	-8.50	0.08	-1.02	0.22	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	120.91-10.2%	134.70+26.6%	106.40+32.0%	80.59-51.0%	164.35+164.0%	62.26
Other Income	3.97	2.34	1.65	3.45	2.72	2.21
Total Income	124.88-8.9%	137.04+26.8%	108.04+28.6%	84.04-49.7%	167.07+159.1%	64.47
Expenditure	-135.10-7.6%	-125.57-15.3%	-108.92-20.9%	-90.08+11.8%	-102.16-25.4%	-81.44
Interest	-3.33	-2.30	-4.80	-11.57	-19.92	-25.55
PBDT	0	0	0	0	0	0
EBITDA	-2.40-113.4%	17.88+22.7%	14.57-6.6%	15.60-84.0%	97.50+576.1%	14.42
Depreciation	-8.46	-6.45	-12.29	-13.52	-15.39	-8.05
EBIT	-10.86-195.0%	11.43+401.3%	2.28+9.6%	2.08-97.5%	82.11+1189.0%	6.37
PBT	-33.24-389.8%	11.47+1333.3%	-0.93+93.0%	-13.21-121.9%	60.24+427.4%	-18.40
Tax	0.95	-3.25	-1.34	-0.08	-20.34	3.94
Equity	35.69	35.69	0	0	0	0
OPM (%)	-26.61	8.37	-1.00	-16.00	36.00	-29.00
Net Profit	-32.29-492.3%	8.23+462.6%	-2.27+82.9%	-13.29-133.3%	39.90+375.9%	-14.46
NPM (%)	-25.86	6.00	-2.00	-16.00	24.00	-22.00
EPS (Rs)	0-100.0%	2.28+416.7%	-0.72+84.5%	-4.65-133.5%	13.87+373.0%	-5.08
CEPS	0	2.28	-0.72	-4.65	13.87	-5.08

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	42.31+28.1%	28.03	30.73	36.66	33.03	128.45
Other Income	0.42	0.61	1.16	1.09	0.63	3.50
Total Income	42.73+26.9%	28.64	31.89	37.75	33.66	131.94
Interest	1.01	0.70	0.82	0.79	0.85	3.33
Expenditure	-40.78-26.3%	-37.23	-32.05	-42.14	-32.30	-143.72
PBDT	0	0	0	0	0	0
EBITDA	4.55+23.3%	-6.46	1.66	-2.54	3.69	-3.49
Depreciation	-2.01	-2.04	-2.16	-2.15	-2.11	-8.46
EBIT	2.54+60.8%	-8.50	-0.50	-4.69	1.58	-11.95
PBT	1.95+44.4%	-8.59	0	0	1.35	-11.78
Tax	0.10	0.52	0.01	1.17	-0.36	1.34
Equity	36.15	35.69	0	0	35.69	35.69
OPM	4.56	-29.99	0.00	0.00	4.01	-8.93
Net Profit	2.05+105.0%	-8.07	-0.15	-3.21	1	-10.44
NPM	4.80	-28.18	-0.47	-8.51	2.97	-7.91
EPS	0.57+128.0%	-2.13	0	-0.94	0.25	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	128.44-7.3%	138.50+24.5%	111.20+19.5%	93.07-52.0%	194.09+125.0%	86.25
Other Income	3.50	2.23	1.46	3.40	2.09	1.56
Total Income	131.94-6.2%	140.73+24.9%	112.65+16.8%	96.47-50.8%	196.18+123.4%	87.81
Expenditure	-143.72-10.9%	-129.60-14.5%	-113.17-10.7%	-102.25+21.6%	-130.41-29.3%	-100.83
Interest	-3.33	-2.27	-4.89	-11.87	-20.13	-25.94
PBDT	0	0	0	0	0	0
EBITDA	-3.49-119.5%	17.94+14.1%	15.72-6.7%	16.84-83.4%	101.16+414.0%	19.68
Depreciation	-8.46	-6.77	-12.80	-14.15	-17.35	-8.32
EBIT	-11.95-207.0%	11.17+282.5%	2.92+8.6%	2.69-96.8%	83.81+637.8%	11.36
PBT	-11.78-205.9%	11.12+1295.7%	-0.93+92.9%	-13.17-122.2%	59.25+519.0%	-14.14
Tax	1.34	-3.19	-1.69	0.02	-20.80	4.05
Equity	35.69	35.69	0	0	0	0
OPM (%)	-8.93	7.91	-0.83	-13.65	30.20	-16.11
Net Profit	-10.44-231.7%	7.93+402.7%	-2.62+80.1%	-13.15-133.7%	39+437.4%	-11.56
NPM (%)	-7.91	5.64	-2.33	-13.63	19.88	-13.16
EPS (Rs)	0-100.0%	2.22+381.0%	-0.79+82.9%	-4.63-134.1%	13.57+433.4%	-4.07
CEPS	0	2.22	-0.79	-4.63	13.57	-4.07

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split